Rothschild Investment Corp Ab Cellera Biologics Inc. Transaction History

Rothschild Investment Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 18, 2023	SELL	$5.66 - $7.59 $38,488 - $51,612	-6,800 Reduced 22.44%	23,500 $152,000
Q1 2023 Apr 24, 2023	SELL	$7.31 - $11.18 $35,088 - $53,664	-4,800 Reduced 13.68%	30,300 $228,000
Q4 2022 Jan 19, 2023	SELL	$9.48 - $14.52 $62,568 - $95,832	-6,600 Reduced 15.83%	35,100 $356,000
Q3 2022 Oct 21, 2022	BUY	$9.2 - $13.68 $80,040 - $119,016	8,700 Added 26.36%	41,700 $412,000
Q1 2022 Apr 18, 2022	BUY	$7.46 - $14.14 $52,220 - $98,980	7,000 Added 26.92%	33,000 $322,000
Q4 2021 Jan 24, 2022	BUY	$12.99 - $17.73 $337,740 - $460,980	26,000 New	26,000 $372,000

153

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $787M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Rothschild Investment Corp , based on Form 13F filings with the SEC.

Stay updated on Rothschild Investment Corp with notifications on news.